Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Effects of ADHD Medication on Cognition and Quality of Life (LMA)
NCT03250013Phase 4Completed
- Sponsor
- University of Gothenburg
- Start
- Apr 2014
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate, amphetamine, atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by University of Gothenburg. Started Apr 2014; status: completed.
02
Drugs
methylphenidateamphetamineatomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT03250013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03250013.